Application of the New IMWG/IMS High-Risk Classification for Multiple Myeloma: Analysis of a Large Real-World Romanian Cohort
Sorina Nicoleta Badelita, Sinziana Barbu, Onda-Tabita Calugaru, Cerasela Jardan, Codruta Delia Popa, Larisa Zidaru, Mihai Emanuel Himcinschi, Bogdan Nicolas Smadu, Iulia Ursuleac, Daniel Coriu · 2026
Read Application of the New IMWG/IMS High-Risk Classification for Multiple Myeloma: Analysis of a Large Real-World Romanian Cohort by Sorina Nicoleta Badelita, Sinziana Barbu, Onda-Tabita Calugaru, Cerasela Jardan, Codruta Delia Popa, Larisa Zidaru, Mihai Emanuel Himcinschi, Bogdan Nicolas Smadu, Iulia Ursuleac, Daniel Coriu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13207379.txt.
Description
Sorina Nicoleta Badelita and nine co-authors test a new risk scheme for multiple myeloma in Romania in 2026. Myeloma is a blood cancer of plasma cells with wide variation between patients. New international rules sharpen the high-risk label using gene faults, including damage to a key guard gene and chromosome one changes.
The team rechecked 738 patients diagnosed from 2017 to 2025, with gene test data for 408. A quarter of those were relabeled high-risk under the new rules. Their median survival ran about fifty-two months against sixty-eight for standard risk. Time without disease growth also split clearly, backing the scheme in real-world care.
Catalog record
| CREATOR | Sorina Nicoleta Badelita, Sinziana Barbu, Onda-Tabita Calugaru, Cerasela Jardan, Codruta Delia Popa, Larisa Zidaru, Mihai Emanuel Himcinschi, Bogdan Nicolas Smadu, Iulia Ursuleac, Daniel Coriu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |